Stock market news

Lambumiz

Lambumiz's net profit under IFRS for 6 months of 2025 amounted to ₽138 million, an increase of 10.1% compared to ₽125.34 million in the previous year. Revenue decreased by 2.8% to ₽1.38 billion from ₽1.42 billion a year earlier.

Yakovlev

Yakovlev's net profit under IFRS for 6 months of 2025 amounted to 2.54 billion rubles, an increase of 28.3% compared to 1.98 billion rubles in the previous year.

Bashinformsvyaz

Bashinformsvyaz's net profit under IFRS for 6 months of 2025 amounted to ₽1.76 billion, an increase of 8% compared to ₽1.63 billion in the previous year. Revenue increased by 5.2% to ₽11.96 billion from ₽11.37 billion a year earlier.

Aeroflot

Aeroflot's net profit under IFRS for 6 months of 2025 amounted to 74.3 billion rubles, an increase of 75.7% compared to 42.3 billion rubles in the previous year. Revenue increased by 10% to ₽414.8 billion from ₽377.2 billion a year earlier.

Ozon Pharmaceuticals

Board of Directors of Ozon Pharmaceuticals recommended that dividends be paid for 6 months 2025 in the amount of ₽0.25 per ordinary share. The last day of the purchase of securities to receive dividends is October 3, 2025. Dividend yield may amount to 0.44%.

KuibyshevAzot

KuibyshevAzot's net profit under IFRS for 6 months of 2025 amounted to ₽3.46 billion, a decrease of almost 2 times compared to ₽6.61 billion in the previous year. Revenue increased by 1% to ₽44.08 billion from ₽43.63 billion a year earlier.

Territorial Generating Company № 2

Net profit of Territorial Generating Company No. 2 under IFRS for 6 months of 2025 amounted to 2.92 billion rubles against a loss of 0.012 billion rubles in the previous year. Revenue increased by 13.4% to ₽34.7 billion from ₽30.6 billion a year earlier.

MD Medical Group Investments

MD Medical has no plans to acquire the Invitro laboratory network, and there have been no relevant negotiations, said Mark Kurtzer, founder and CEO of the group of companies. Earlier, Vedomosti sources reported that MD Medical was interested in buying Invitro and had already begun evaluating the business of the laboratory network.

LUKOIL

Lukoil's Board of Directors has decided to repay 76 million quasi-treasury shares of the company. In addition, the cost of acquiring shares in the first half of 2025 will not be taken into account when calculating adjusted free cash flow and for the purposes of calculating the dividend.

Moscow confectionery factory Krasny Oktyabr

Loss of Krasny Oktyabr under IFRS for 6 months of 2025 amounted to ₽1.58 billion against a profit of ₽0.214 billion in the previous year. Revenue decreased by 7.9% to ₽9.58 billion from ₽10.4 billion a year earlier.